Código QR

Case Report: FIA plus venetoclax in a patient on hemodialysis

The safe and effective delivery of curative cytotoxic chemotherapy for acute myeloid leukemia (AML) in patients receiving intermittent hemodialysis (IHD) for end-stage renal disease (ESRD) remains a clinical challenge; pharmacological and logistical barriers necessitate close interdisciplinary coord...

Descrición completa

Gardado en:
Principais autores: Jacob E. Herstein, Kayleigh R. Marx, J. Michael Savoy, Wei Ying Jen, Musa Yilmaz, Nicholas J. Short, Ghayas C. Issa, Farhad Ravandi, Tapan M. Kadia, Naval G. Daver, Courtney D. DiNardo
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2026-01-01
Series:Frontiers in Oncology
Assuntos:
acute myeloid leukemia
case report
chemotherapy
hematologic oncology
hemodialysis
Acceso en liña:https://www.frontiersin.org/articles/10.3389/fonc.2025.1740357/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares